AstraZeneca To Pay $103M To Settle AWP Claims
AstraZeneca Pharmaceuticals LP agreed Friday to pay $103 million to settle claims from several classes of consumers and third-party purchasers in a multidistrict litigation accusing drugmakers of scheming to artificially boost...To view the full article, register now.
Already a subscriber? Click here to view full article